Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemangioma, Vascular Anomalies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01016756
What this trial is testing

Genetic Analysis of PHACE Syndrome (Hemangioma With Other Congenital Anomalies)

Who this might be right for
PHACE Syndrome
Medical College of Wisconsin 341
Testing effectiveness (Phase 2)WithdrawnNCT01997255
What this trial is testing

Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)

Who this might be right for
Sturge Weber Syndrome
Baylor College of Medicine
Not applicableUnknownNCT00490607
What this trial is testing

A Prospective Study Comparing the Incidence of Infantile Hemangiomas Following Normal Pregnancies Versus Pregnancies Complicated by Placental Abnormalities

Who this might be right for
Hemangioma
Rady Children's Hospital, San Diego
Not applicableLooking for participantsNCT06214767
What this trial is testing

Study on Treatment Decision-Making and Prognostic Follow-Up for Untreated Cerebral Cavernous Malformations

Who this might be right for
Hemangioma, Cavernous, Central Nervous System
Beijing Tiantan Hospital 1,200
Not applicableLooking for participantsNCT02399527
What this trial is testing

Lymphatic Anomalies Registry for the Assessment of Outcome Data

Who this might be right for
Lymphatic MalformationGeneralized Lymphatic Anomaly (GLA)Central Conducting Lymphatic Anomaly+7 more
Boston Children's Hospital 1,000
Not applicableWithdrawnNCT04344626
What this trial is testing

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

Who this might be right for
EpilepsyFocal Cortical DysplasiaTuberous Sclerosis+7 more
University of California, Los Angeles
Not applicableLooking for participantsNCT05477680
What this trial is testing

Intraoperative Brain Shift Calculation Study

Who this might be right for
Tumor, BrainCavernomaArteriovenous Malformations+1 more
Sklifosovsky Institute of Emergency Care 100
Testing effectiveness (Phase 2)Study completedNCT00975819
What this trial is testing

Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies

Who this might be right for
Kaposiform HemangioendotheliomasTufted AngiomaCapillary Venous Lymphatic Malformation+6 more
Denise Martin Adams 61
Not applicableLooking for participantsNCT06056635
What this trial is testing

A Prospective Study on the Role of Karl Storz Curved and Straight Fetoscopes (11508AAK and 11506AAK) for Fetoscopic Intrauterine Procedures

Who this might be right for
Fetal ConditionsMaternal; ProcedurePregnancy Related+7 more
Boston Children's Hospital 50
Post-approval studies (Phase 4)UnknownNCT04921722
What this trial is testing

Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies

Who this might be right for
Kaposiform HemangioendotheliomaTufted AngiomaSuperficial Vascular Anomalies+1 more
Children's Hospital of Fudan University 75
Testing effectiveness (Phase 2)Study completedNCT02859441
What this trial is testing

A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab

Who this might be right for
Von Hippel-Lindau Syndrome
National Eye Institute (NEI) 3
Testing effectiveness (Phase 2)Study completedNCT02603328
What this trial is testing

Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial

Who this might be right for
Cerebral Cavernous Malformation
University of Chicago 80
Testing effectiveness (Phase 2)Ended earlyNCT01266070
What this trial is testing

TKI 258 in Von Hippel-Lindau Syndrome (VHL)

Who this might be right for
Von Hippel-Lindau Syndrome
M.D. Anderson Cancer Center 6
Early research (Phase 1)UnknownNCT02496013
What this trial is testing

Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB

Who this might be right for
Arteriovenous MalformationHemangiomaNeoplasms Lymph Nodes+1 more
Peking Union Medical College Hospital 70
Very early researchEnded earlyNCT01764451
What this trial is testing

Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins

Who this might be right for
Cavernous Angioma, FamilialCerebral Cavernous MalformationsCerebral Cavernous Hemangioma
University of New Mexico 12
Early research (Phase 1)Study completedNCT02108002
What this trial is testing

Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)

Who this might be right for
Von Hippel-Lindau Disease
National Institute of Neurological Disorders and Stroke (NINDS) 7
Not applicableLooking for participantsNCT05424016
What this trial is testing

Propranolol and Von Hippel-Lindau Disease

Who this might be right for
Hemangioblastoma of CNSVon Hippel-Lindau Disease
Assistance Publique - Hôpitaux de Paris 85
Not applicableLooking for participantsNCT07183644
What this trial is testing

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients

Who this might be right for
Port Wine Stains
University of Texas Southwestern Medical Center 200
Post-approval studies (Phase 4)Study completedNCT02625389
What this trial is testing

Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures

Who this might be right for
Congenital HemangiomaHemangioendotheliomaAngiosarcoma+1 more
Guerbet 132
Testing effectiveness (Phase 2)Study completedNCT05085561
What this trial is testing

The Symptomatic Cerebral Cavernous Malformation Trial of REC-994

Who this might be right for
Cerebral Cavernous Malformation
Recursion Pharmaceuticals Inc. 62
Next Page